New York, NY · Founded 2014 · Privately Held (backing)
Developer of a healthcare device designed to reduce sympathetic nerve activity and address the root cause of heart failure. Axon Therapies is based in New York, NY and was founded in 2014. It was valued at $44.5 million at its later-stage round in Jan 2021, the last priced event on record. It has raised $75.8 million across 3 recorded rounds; the latest was a $7.5 million early-stage round in Jan 2019.
PMV mark · valuation
$44.5M
Oct 2026
Priced at
its later-stage round
Jan 2021
Total raised
$75.8M
Last round
Early Stage VC
Jan 2019
No prints on record
No secondary trades in Axon Therapies shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Axon Therapies with a free account
·Watch Axon Therapies: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Axon Therapies stock.
